San Diego, CA, United States of America

Servet Buyuktimkin

This inventor holds 20 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Topical Formulations. Top assignees: Nexmed (Holdings) Incorporated, Nuvo Research Inc., Achelios Therapeutics, Inc.. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Servet Buyuktimkin. Retrieved from https://idiyas.com/inventor/servet-buyuktimkin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 3.8

ph-index = 8

Forward Citations = 273(Granted Patents)


Location History:

  • Lawrence, KS (US) (2000 - 2004)
  • San Diego, CA (US) (2013 - 2022)

Company Filing History:


Years Active: 2000-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Topical Anti-Inflammatory
Topical Formulation
Foamable Formulation
Topical Antifungal
Transdermal Delivery
Hormonal Compositions
Prostaglandin Treatments
Erectile Dysfunction
Female Sexual Dysfunction
Highly Permeating Formulations
NSAI Drug Delivery
20 patents (USPTO):Explore Patents

Title: Servet Buyuktimkin: Innovator in Topical Anti-Inflammatory Compositions

Introduction

Servet Buyuktimkin is an accomplished inventor based in San Diego, CA, with an impressive portfolio of 20 patents to his name. His innovative contributions, particularly in the field of topical formulations, have the potential to advance therapeutic options in anti-inflammatory treatments and more.

Latest Patents

Among his latest patents, Buyuktimkin developed a topical anti-inflammatory composition that features a non-steroidal anti-inflammatory drug (NSAID) combined with a unique aqueous carrier system that includes cationic galactomannan gum. This composition also integrates various components, including a lactate ester of a saturated aliphatic alcohol and a monoprotic arylalkanoic acid, aiming to enhance the efficacy of pain relief applications.

Additionally, he has introduced a topical formulation that combines pregabalin with DMSO, a keto acid, and fatty alcohols or esters. The formulation leverages DMSO's properties as a penetration enhancer, facilitating the administration of pregabalin through skin applications. These innovations reflect Buyuktimkin's commitment to improving patient care through advanced delivery systems.

Career Highlights

Servet Buyuktimkin’s career includes significant roles at notable companies, including Nexmed (Holdings) Incorporated and Nuvo Research Inc. His work at these institutions has underscored his expertise in developing novel drug delivery systems that address various medical needs, especially in dermatology and pain management.

Collaborations

Throughout his career, he has collaborated with talented individuals, including Nadir Buyuktimkin and James L. Yeager. These partnerships have played an important role in advancing his research efforts, enabling the development of his successful inventions and patents.

Conclusion

Servet Buyuktimkin continues to make strides in the field of pharmaceutical innovations with his extensive patent portfolio and collaborative efforts. His focus on creating effective topical formulations represents a significant contribution to medical science, showcasing the power of innovation in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…